Nanoparticle-based Drug Delivery

SEP 8, 2026 · JOURNAL ARTICLE

The Impact of Nanoparticles on Proton Therapy: A Review Study

Cancers

A narrative literature review synthesizing preclinical evidence on nanoparticle radiosensitizers for proton therapy; raises mechanistic questions and identifies research gaps rather than reporting new empirical results or clinical outcomes.

SEP 8, 2026 · JOURNAL ARTICLE

Mesoporous silica nanoparticles as an advanced tool for cancer therapy

Next Nanotechnology

This is a narrative review assessing MSN technology for cancer therapy without reporting original clinical trial data, efficacy comparisons, or quantified outcomes; it raises mechanistic and design questions rather than answering them with empirical evidence.

SEP 8, 2026 · JOURNAL ARTICLE

Targeted Strategies for Treatment of Colorectal Cancer: Exploring the Use of Aptamers and Gold Nanoparticles

Molecules

This is a narrative review exploring preclinical aptamer and gold nanoparticle strategies for colorectal cancer, presenting mechanistic concepts and projected benefits without clinical trial data or empirical validation.

SEP 8, 2026 · JOURNAL ARTICLE

Bufalin-Loaded Multifunctional Nanodrugs for Cancer Therapy: Mechanisms, Delivery Strategies, and Translational Perspectives

Biomolecules

This is a narrative review synthesizing preclinical mechanistic evidence and nanocarrier design strategies for bufalin, with no clinical trials, efficacy data, or comparative outcomes reported.

SEP 7, 2026 · JOURNAL ARTICLE

Cu-deficient Cu–Fe Prussian blue analogues enable phosphate/GSH-coupled redox remodeling for catalytic/sonodynamic cancer therapy

Journal of Nanobiotechnology

Early-stage preclinical study demonstrating a novel nanoparticle design in cell culture and a single murine tumor model, without clinical translation, efficacy comparators, or mechanistic validation beyond correlative evidence.

SEP 7, 2026 · JOURNAL ARTICLE

Spin-state modulation at Fe-O-Cu interfaces enables dual ferroptotic-cuproptotic cancer therapy

Journal of Nanobiotechnology

This is a mechanistic and proof-of-concept study demonstrating a novel nanomaterial design principle in cancer cells and a mouse model, but lacks comparative efficacy data, clinical endpoints, or phase-appropriate trial design to support clinical recommendations.

SEP 5, 2026 · JOURNAL ARTICLE

Ufasomal Nanocarriers for Enhanced Cardiac Delivery of Nifedipine: A Novel Strategy to Mitigate Doxorubicin-Induced Cardiotoxicity in Breast Cancer Therapy

Journal of Drug Targeting

Early-stage preclinical study in an animal model demonstrating formulation optimization and proof-of-concept for a nanocarrier delivery strategy; lacks human efficacy data and clinical outcomes.

SEP 4, 2026 · JOURNAL ARTICLE

Juniperus phoenicea extract-loaded nanostructured lipid carriers for potent antimicrobial and anticancer combination therapy

Amb Express

In vitro study of plant extract nanoparticles showing antimicrobial and anticancer activity in cell culture with no animal or clinical data; requires in vivo validation before clinical relevance can be assessed.